Warning letter
Jason Martindale: warning letter of Oct 2, 2013
FDA warning letter 410932 · New York District Office
Key facts
| Reference number | 410932 |
|---|---|
| Company | Jason Martindale |
| Subject | Illegal Drug Residue |
| Issue date | Oct 2, 2013 |
| Posted date | Oct 2, 2013 |
| Issuing office | New York District Office |
| Product type | Veterinary |
| CFR sections cited | 530, 530.3(a), 530.11(a), 530.11(c) |
| Inspection city | Gansevoort |
| Inspection ZIP | 12831 |
| Inspection start date | May 30, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: